NCT00545116 Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women Status COMPLETED Phase PHASE2
NCT00544180 ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week Status TERMINATED Phase PHASE4
NCT00542425 Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE2
NCT00540878 A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women Status COMPLETED Phase PHASE1
NCT00536653 Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer Status COMPLETED Phase NA
NCT00535860 Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis Status COMPLETED Phase PHASE2
NCT00532337 Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis Status COMPLETED Phase PHASE2
NCT00532077 A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women Status COMPLETED Phase PHASE1
NCT00525798 A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D Status COMPLETED Phase PHASE3
NCT00523835 Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter Syndrome Status COMPLETED Phase N/A
NCT00523341 Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis Status COMPLETED Phase PHASE3
NCT00520052 Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer Status COMPLETED Phase NA
NCT00519857 Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) Status COMPLETED Phase PHASE3
NCT00515593 PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE) Status COMPLETED Phase N/A
NCT00515463 A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density Status COMPLETED Phase PHASE3
NCT00512499 Strategies to Treat Osteoporosis Following a Fragility Fracture Status COMPLETED Phase NA